Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.67
- Piotroski Score 2.00
- Grade Neutral
- Symbol (TALS)
- Company Talaris Therapeutics, Inc.
- Price $2.72
- Changes Percentage (-0.73%)
- Change -$0.02
- Day Low $2.69
- Day High $2.80
- Year High $3.29
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR002 in deceased donor kidney transplants; FCR001 in patients with a severe form of scleroderma; and FCR001 for one or more severe non-malignant blood, immune, or metabolic disorders. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky.
- Last Earnings 10/19/2023
- Ex-Dividend for 5/16 Dividend 10/19/2023
- Dividend Payable 10/20/2023
- Today N/A
- Next Earnings (Estimated) 11/08/2023
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.74
- Trailing P/E Ratio -1.5632183908046
- Forward P/E Ratio -1.5632183908046
- P/E Growth -1.5632183908046
- Net Income $-68,728,000
Income Statement
Quarterly
Annual
Latest News of TALS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Wood helps Avalanche beat Ovechkin-less Capitals 2-1
The Colorado Avalanche defeated the Washington Capitals 2-1 with Miles Wood scoring the winning goal. Mikko Rantanen also scored. Alexandar Georgiev made 29 saves for his fourth consecutive win. Capit...
By AP NEWS | 15 hours ago -
America's Best Children's Hospitals 2024
Children's hospitals play a vital role in communities, addressing issues beyond healthcare. These institutions prioritize patient care while sharing research for public benefit. Newsweek's annual rank...
By Newsweek | 1 day ago -
Wheaton Precious Metals Corp. (WPM): A Top Silver Mining Stock to Buy Right Now
The article discusses the rise in silver prices due to industrial demand, geopolitical tensions, and increased usage in technology like solar panels. It highlights the growth in silver demand for sola...
By Yahoo! Finance | 1 day ago
